Literature DB >> 9867213

Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats.

Y Fujita1, H Kojima, H Hidaka, M Fujimiya, A Kashiwagi, R Kikkawa.   

Abstract

Otsuka Long-Evans Tokushima Fatty (OLETF) rats are reported to be obese Type II (non-insulin-dependent) diabetic rats with insulin resistance and impaired insulin secretion. To investigate the contribution of intestinal glucose absorption to postprandial hyperglycaemia, we determined the plasma xylose concentrations after an 0.8 g/kg oral xylose load which was used as a test of small intestinal glucose absorption in 6-week-old OLETF rats and weight-matched Long-Evans Tokushima Otsuka (LETO) rats. An oral glucose tolerance test showed that OLETF rats developed hyperglycaemia at 60 and 90 min after the glucose load, though the fasting plasma glucose concentration, insulin concentration and insulin-induced in vivo glucose utilization rate were similar. Consistently, in an oral D-xylose loading test, the peak concentration of plasma xylose in OLETF rats was increased by 58.7% compared with that of LETO rats (p < 0.005). The disappearance rate of plasma xylose concentrations after intravenous xylose loading did not differ between the two strains. Co-treatment with 0.4 g/kg phlorizin, a specific inhibitor of sodium-dependent glucose transporter 1 (SGLT1), abolished both plasma glucose and xylose concentrations after the loads. Morphological studies showed that both the small intestinal wet weight and surface area were 30% larger in the OLETF rats than in the LETO rats. Furthermore, the SGLT1 mRNA content of OLETF rats also increased compared with LETO rats. These results suggest that an increased SGLT1 expression concomitant with intestinal hypertrophy in OLETF rats is partly associated with postprandial hyperglycaemia before the onset of insulin resistance and hyperinsulinaemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867213     DOI: 10.1007/s001250051092

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

Review 1.  Development of SGLT1 and SGLT2 inhibitors.

Authors:  Timo Rieg; Volker Vallon
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

2.  Iron Overload Coordinately Promotes Ferritin Expression and Fat Accumulation in Caenorhabditis elegans.

Authors:  Haizhen Wang; Xue Jiang; Jieyu Wu; Linqiang Zhang; Jingfei Huang; Yuru Zhang; Xiaoju Zou; Bin Liang
Journal:  Genetics       Date:  2016-03-26       Impact factor: 4.562

3.  Metabolic surgery and intestinal gene expression: Digestive tract and diabetes evolution considerations.

Authors:  Marcos Ricardo da Silva Rodrigues; Marco Aurelio Santo; Giovani Marino Favero; Elaine Cristina Vieira; Roberto Ferreira Artoni; Viviane Nogaroto; Egberto Gaspar de Moura; Patricia Lisboa; Fabio Quirillo Milleo
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  What does sodium-glucose co-transporter 1 inhibition add: Prospects for dual inhibition.

Authors:  Jessica A Dominguez Rieg; Timo Rieg
Journal:  Diabetes Obes Metab       Date:  2019-04       Impact factor: 6.577

5.  Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.

Authors:  S L Conarello; G Jiang; J Mu; Z Li; J Woods; E Zycband; J Ronan; F Liu; R Sinha Roy; L Zhu; M J Charron; B B Zhang
Journal:  Diabetologia       Date:  2006-11-28       Impact factor: 10.122

6.  Strong association of serum- and glucocorticoid-regulated kinase 1 with peripheral and adipose tissue inflammation in obesity.

Authors:  M H Schernthaner-Reiter; F Kiefer; M Zeyda; T M Stulnig; A Luger; G Vila
Journal:  Int J Obes (Lond)       Date:  2015-03-26       Impact factor: 5.095

Review 7.  Renal tubular transport and the genetic basis of hypertensive disease.

Authors:  Florian Lang; Giovambattista Capasso; Matthias Schwab; Siegfried Waldegger
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

Review 8.  Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.

Authors:  Panai Song; Akira Onishi; Hermann Koepsell; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2016-04-12       Impact factor: 6.902

9.  Farnesoid X receptor is essential for normal glucose homeostasis.

Authors:  Ke Ma; Pradip K Saha; Lawrence Chan; David D Moore
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

10.  Metabolic-sensing of the skeletal muscle clock coordinates fuel oxidation.

Authors:  Hongshan Yin; Weini Li; Somik Chatterjee; Xuekai Xiong; Pradip Saha; Vijay Yechoor; Ke Ma
Journal:  FASEB J       Date:  2020-03-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.